Ubiquinol Cytochrome C Reductase Core Protein I (UQCRC1) Mouse Monoclonal Antibody [Clone ID: OTI1G2]

CAT#: TA800033

UQCRC1 mouse monoclonal antibody, clone OTI1G2 (formerly 1G2)

Product Images

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY UQCRC1 (RC203299, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-UQCRC1. Positive lysates LY401151 (100ug) and LC401151 (20ug) can be purchased separately from OriGene.

• 

  Western blot analysis of extracts (35ug) from 9 different cell lines by using anti-UQCRC1 monoclonal antibody (HepG2: human; HeLa: human; SVT2: mouse; A549: human; COS7: monkey; Jurkat: human; MDCK: canine; PC12: rat; MCF7: human).

• 

  Anti-UQCRC1 mouse monoclonal antibody (TA800033) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY UQCRC1 (RC203299).

Specifications

Product Data

• Clone Name: OTI1G2
• Applications: IF, WB
• Recommended Dilution: WB 1:500~1000, IF 1:100
• Reactivities: Human, Mouse, Rat
• Host: Mouse
• Isotype: IgG1
• Clonality: Monoclonal
• Immunogen: Human recombinant protein fragment corresponding to amino acids 46-305 of human UQCRC1 (NP_003356) produced in E.coli.
• Formulation: PBS (PH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.
• Concentration: 1 mg/ml
• Purification: Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G)
• Conjugation: Unconjugated
• Storage: Store at -20°C as received.
• Stability: Stable for 12 months from date of receipt.
• Predicted Protein Size: 52.5 kDa
• Gene Name: ubiquinol-cytochrome c reductase core protein I
• Database Link:
  NP_003356
  Entrez Gene 22273 MouseEntrez Gene 301011 RatEntrez Gene 7384 Human
  UniProt ID P31930
• Synonyms: D3S3191; QCR1; UQCR1

Reference Data

• Protein Families: Druggable Genome, Protease
• Protein Pathways: Alzheimer's disease, Cardiac muscle contraction, Huntington's disease, Metabolic pathways, Oxidative phosphorylation, Parkinson's disease